annual operating expenses:
$11.99B-$423.48M(-3.41%)Summary
- As of today (September 17, 2025), TAK annual total operating expenses is $11.99 billion, with the most recent change of -$423.48 million (-3.41%) on March 1, 2025.
- During the last 3 years, TAK annual operating expenses has fallen by -$764.97 million (-6.00%).
- TAK annual operating expenses is now -12.33% below its all-time high of $13.67 billion, reached on March 31, 2020.
Performance
TAK Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$2.77B-$591.85M(-17.62%)Summary
- As of today (September 17, 2025), TAK quarterly total operating expenses is $2.77 billion, with the most recent change of -$591.85 million (-17.62%) on June 1, 2025.
- Over the past year, TAK quarterly operating expenses has dropped by -$47.16 million (-1.68%).
- TAK quarterly operating expenses is now -41.28% below its all-time high of $4.71 billion, reached on March 31, 2015.
Performance
TAK quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TAK Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | -1.7% |
| 3 y3 years | -6.0% | -4.2% |
| 5 y5 years | -12.3% | -3.8% |
TAK Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | at low | -17.6% | at low |
| 5 y | 5-year | -12.3% | at low | -17.6% | at low |
| alltime | all time | -12.3% | +633.1% | -41.3% | +199.5% |
TAK Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.77B(-17.6%) |
| Mar 2025 | $11.99B(-3.4%) | $3.36B(+16.1%) |
| Dec 2024 | - | $2.89B(-2.7%) |
| Sep 2024 | - | $2.97B(+5.7%) |
| Jun 2024 | - | $2.81B(-13.2%) |
| Mar 2024 | $12.41B(+2.6%) | $3.24B(+5.1%) |
| Dec 2023 | - | $3.08B(+2.0%) |
| Sep 2023 | - | $3.02B(+1.2%) |
| Jun 2023 | - | $2.99B(-4.9%) |
| Mar 2023 | $12.10B(-5.1%) | $3.14B(+1.4%) |
| Dec 2022 | - | $3.10B(+6.3%) |
| Sep 2022 | - | $2.91B(+0.8%) |
| Jun 2022 | - | $2.89B(-8.5%) |
| Mar 2022 | $12.75B(+0.1%) | $3.16B(-0.2%) |
| Dec 2021 | - | $3.16B(+0.8%) |
| Sep 2021 | - | $3.14B(+0.2%) |
| Jun 2021 | - | $3.13B(-4.5%) |
| Mar 2021 | $12.74B(-6.9%) | $3.28B(+0.6%) |
| Dec 2020 | - | $3.26B(+3.3%) |
| Sep 2020 | - | $3.15B(+9.6%) |
| Jun 2020 | - | $2.88B(-18.2%) |
| Mar 2020 | $13.67B(+43.5%) | $3.52B(+0.5%) |
| Dec 2019 | - | $3.50B(+11.5%) |
| Sep 2019 | - | $3.14B(-3.2%) |
| Jun 2019 | - | $3.24B(-12.8%) |
| Mar 2019 | $9.53B(+10.8%) | $3.72B(+81.1%) |
| Dec 2018 | - | $2.05B(-1.4%) |
| Sep 2018 | - | $2.08B(+7.0%) |
| Jun 2018 | - | $1.95B(-19.1%) |
| Mar 2018 | $8.60B(+0.1%) | $2.41B(+12.9%) |
| Dec 2017 | - | $2.13B(+2.5%) |
| Sep 2017 | - | $2.08B(+4.3%) |
| Jun 2017 | - | $1.99B(-15.6%) |
| Mar 2017 | $8.59B(+4.7%) | $2.36B(+17.4%) |
| Dec 2016 | - | $2.01B(-7.0%) |
| Sep 2016 | - | $2.16B(+5.4%) |
| Jun 2016 | - | $2.05B(-11.6%) |
| Mar 2016 | $8.21B(-3.9%) | $2.32B(+10.7%) |
| Dec 2015 | - | $2.10B(+10.3%) |
| Sep 2015 | - | $1.90B(-4.9%) |
| Jun 2015 | - | $2.00B(-57.6%) |
| Mar 2015 | $8.54B(-6.5%) | $4.71B(+112.7%) |
| Dec 2014 | - | $2.22B(-4.2%) |
| Sep 2014 | - | $2.31B(+6.0%) |
| Jun 2014 | - | $2.18B(-22.4%) |
| Mar 2014 | $9.14B(-10.3%) | $2.81B(+8.1%) |
| Dec 2013 | - | $2.60B(+3.1%) |
| Sep 2013 | - | $2.52B(+0.7%) |
| Jun 2013 | - | $2.51B(-19.0%) |
| Mar 2013 | $10.19B | $3.09B(+4.8%) |
| Dec 2012 | - | $2.95B(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $2.92B(+0.7%) |
| Jun 2012 | - | $2.90B(-9.0%) |
| Mar 2012 | $9.19B(+7.1%) | $3.19B(+9.3%) |
| Dec 2011 | - | $2.92B(+33.5%) |
| Sep 2011 | - | $2.19B(+10.0%) |
| Jun 2011 | - | $1.99B(-25.9%) |
| Mar 2011 | $8.58B(+4.7%) | $2.68B(+27.5%) |
| Dec 2010 | - | $2.10B(+6.4%) |
| Sep 2010 | - | $1.98B(+3.4%) |
| Jun 2010 | - | $1.91B(-14.8%) |
| Mar 2010 | $8.19B(-12.6%) | $2.24B(+9.3%) |
| Dec 2009 | - | $2.05B(+0.9%) |
| Sep 2009 | - | $2.04B(+8.9%) |
| Jun 2009 | - | $1.87B(+3.2%) |
| Mar 2009 | $9.37B(+59.1%) | $1.81B(+24.9%) |
| Dec 2008 | - | $1.45B(-19.0%) |
| Sep 2008 | - | $1.79B(-41.4%) |
| Jun 2008 | - | $3.06B(+48.5%) |
| Mar 2008 | $5.89B(+21.4%) | - |
| Mar 2008 | - | $2.06B(+52.7%) |
| Dec 2007 | - | $1.35B(-1.9%) |
| Sep 2007 | - | $1.37B(+18.2%) |
| Jun 2007 | - | $1.16B(-14.1%) |
| Mar 2007 | $4.85B(+4.1%) | - |
| Mar 2007 | - | $1.35B(+15.4%) |
| Dec 2006 | - | $1.17B(+1.2%) |
| Sep 2006 | - | $1.16B(-0.6%) |
| Jun 2006 | - | $1.17B(-13.2%) |
| Mar 2006 | $4.66B(+9.2%) | - |
| Mar 2006 | - | $1.34B(+25.1%) |
| Dec 2005 | - | $1.08B(-8.4%) |
| Sep 2005 | - | $1.17B(+13.4%) |
| Jun 2005 | - | $1.03B(-23.7%) |
| Mar 2005 | $4.27B(+8.2%) | - |
| Mar 2005 | - | $1.36B(+27.2%) |
| Dec 2004 | - | $1.07B(+12.5%) |
| Sep 2004 | - | $947.61M(+2.6%) |
| Jun 2004 | - | $923.79M |
| Mar 2004 | $3.94B(+10.4%) | - |
| Mar 2003 | $3.57B(+15.5%) | - |
| Mar 2002 | $3.09B(+8.9%) | - |
| Mar 2001 | $2.84B(-1.1%) | - |
| Mar 2000 | $2.87B(+36.7%) | - |
| Mar 1999 | $2.10B(-8.1%) | - |
| Mar 1998 | $2.28B(-1.7%) | - |
| Mar 1997 | $2.32B(-12.2%) | - |
| Mar 1996 | $2.65B(+4.9%) | - |
| Mar 1995 | $2.52B(+7.6%) | - |
| Mar 1994 | $2.35B(+16.0%) | - |
| Mar 1993 | $2.02B(+14.3%) | - |
| Mar 1992 | $1.77B(+8.2%) | - |
| Mar 1991 | $1.64B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total operating expenses?
- What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total operating expenses?
The current annual operating expenses of TAK is $11.99B
What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total operating expenses is $13.67B
What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
Over the past year, TAK annual total operating expenses has changed by -$423.48M (-3.41%)
What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
The current quarterly operating expenses of TAK is $2.77B
What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total operating expenses is $4.71B
What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
Over the past year, TAK quarterly total operating expenses has changed by -$47.16M (-1.68%)